These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21770186)

  • 1. Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI.
    Oghabian MA; Jeddi-Tehrani M; Zolfaghari A; Shamsipour F; Khoei S; Amanpour S
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5340-4. PubMed ID: 21770186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer.
    Chen H; Wang L; Yu Q; Qian W; Tiwari D; Yi H; Wang AY; Huang J; Yang L; Mao H
    Int J Nanomedicine; 2013; 8():3781-94. PubMed ID: 24124366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
    Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
    J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.
    Hathaway HJ; Butler KS; Adolphi NL; Lovato DM; Belfon R; Fegan D; Monson TC; Trujillo JE; Tessier TE; Bryant HC; Huber DL; Larson RS; Flynn ER
    Breast Cancer Res; 2011 Nov; 13(5):R108. PubMed ID: 22035507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
    Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
    Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI.
    Adolphi NL; Butler KS; Lovato DM; Tessier TE; Trujillo JE; Hathaway HJ; Fegan DL; Monson TC; Stevens TE; Huber DL; Ramu J; Milne ML; Altobelli SA; Bryant HC; Larson RS; Flynn ER
    Contrast Media Mol Imaging; 2012; 7(3):308-19. PubMed ID: 22539401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging.
    Wan X; Song Y; Song N; Li J; Yang L; Li Y; Tan H
    Carbohydr Res; 2016 Jan; 419():33-40. PubMed ID: 26649917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide.
    Koyama T; Shimura M; Minemoto Y; Nohara S; Shibata S; Iida Y; Iwashita S; Hasegawa M; Kurabayashi T; Hamada H; Kono K; Honda E; Aoki I; Ishizaka Y
    J Control Release; 2012 May; 159(3):413-8. PubMed ID: 22300621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
    Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
    Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.
    Jin YH; Hua QF; Zheng JJ; Ma XH; Chen TX; Zhang S; Chen B; Dai Q; Zhang XH
    Cell Physiol Biochem; 2018; 49(1):271-281. PubMed ID: 30138940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
    Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
    Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
    Funovics MA; Kapeller B; Hoeller C; Su HS; Kunstfeld R; Puig S; Macfelda K
    Magn Reson Imaging; 2004 Jul; 22(6):843-50. PubMed ID: 15234453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
    Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
    Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
    Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
    Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
    Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.